Cost-Effectiveness of Umeclidinium/Vilanterol Versus Indacaterol/Glycopyrronium in Symptomatic patients with COPD in the UK

被引：0

作者：

Ismaila, Afisi S. ^{[1
]}

Shah, Dhvani ^{[2
]}

Martin, Alan ^{[3
]}

Kendall, Robyn ^{[4
]}

Noorduyn, Stephen ^{[5
]}

Dasari, Priyadarsini ^{[6
]}

Risebrough, Nancy A. ^{[7
]}

Compton, Chris ^{[8
]}

Noorduyn, Stephen G.

Risebrough, Nancy A. ^{[7
]}

Compton, Chris ^{[8
]}

Noorduyn, Stephen G.

机构：

[1] GSK, Value Evidence & Outcomes, Collegeville, PA USA

[2] ICON Plc, ICON Hlth Econ, Bridgewater, NJ USA

[3] GSK, Value Evidence & Outcomes, Brentford, England

[4] ICON Plc, ICON Hlth Econ, Vancouver, BC, Canada

[5] GSK, Value Evidence & Outcomes, Mississauga, ON, Canada

[6] ICON Plc, ICON Hlth Econ, Houston, TX USA

[7] ICON Plc, ICON Hlth Econ, Burlington, ON, Canada

[8] GSK, R&D Global Med, Brentford, England

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

基金：

芬兰科学院;

关键词：

D O I：

10.1183/13993003.congress-2023.PA1328

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[1] COST-EFFECTIVENESS OF UMECLIDINIUM/VILANTEROL IN SYMPTOMATIC COPD SPANISH PATIENTS
Miravitlles, M.
Galdiz, J. B.
Huerta, A.
Villacampa, A.
Carcedo, D.
Garcia-Rio, F.
VALUE IN HEALTH, 2015, 18 (07) : A500 - A501
[2] Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients
Miravitlles, Marc
Galdiz, Juan B.
Huerta, Alicia
Villacampa, Alba
Carcedo, David
Garcia-Rio, Francisco
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 123 - 132
[3] Cost-Effectiveness of Umeclidinium/Vilanterol (UMEC/VI) Versus Glycopyrrolate/Formoterol Fumarate (GLY/FOR) in Symptomatic Patients with COPD in the UK: The AERISTO trial
Ismaila, Afisi S.
Shah, Dhvani
Martin, Alan
Kendall, Robyn
Noorduyn, Stephen
Dasari, Priyadarsini
Risebrough, Nancy A.
Compton, Chris
Noorduyn, Stephen G.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[4] Comparative effectiveness of umeclidinium/ vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England
Requena, G.
Czira, A.
Banks, V
Wood, R.
Tritton, T.
Castillo, C.
Yeap, J.
Wild, R.
Compton, C.
Duarte, M.
Rothnie, K.
Herth, F.
Ismaila, A.
PNEUMOLOGIE, 2023, 77 : S58 - S59
[5] The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease
Gong, Yinhua
Lin, Chen
Jin, Yifeng
Chen, Rong
CANADIAN RESPIRATORY JOURNAL, 2022, 2022
[6] Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England
Requena, G.
Czira, A.
Banks, V.
Wood, R.
Tritton, T.
Castillo, C.
Yeap, J.
Wild, R.
Compton, C. Chris
Duarte, M.
Rothnie, K.
Ismaila, A.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[7] COST-EFFECTIVENESS ANALYSIS OF UMECLIDINIUM BROMIDE COMPARED TO TIOTROPIUM BROMIDE FOR SYMPTOMATIC PATIENTS WITH COPD IN THE UK
Ismaila, A.
Roberts, G.
Punekar, Y. S.
O'Leary, M.
VALUE IN HEALTH, 2014, 17 (07) : A595 - A595
[8] COST EFFECTIVENESS OF UMECLIDINIUM/VILANTEROL (UMEC/VI) COMBINATION THERAPY AMONG SYMPTOMATIC COPD PATIENTS
Punekar, Y. S.
Roberts, G.
Ismaila, A.
O'Leary, M.
VALUE IN HEALTH, 2014, 17 (07) : A595 - A595
[9] COST-EFFECTIVENESS OF UMECLIDINIUM/VILANTEROL (UMEC/VI) VERSUS ACLIDINIUM/FORMOTEROL (ACL/ FOR) IN PATIENTS WITH COPD IN THE UNITED KINGDOM
Shah, D.
Martin, A.
Kendall, R.
Noorduyn, S. G.
Dasari, P.
Risebrough, N.
Ismaila, A.
VALUE IN HEALTH, 2023, 26 (12) : S190 - S191
[10] Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
Gong, Shiyi
Hu, Hao
Zhao, Kun
Yang, Ting
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 433 - 441

← 1 2 3 4 5 →